Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Total return indices show comprehensive performance by including dividends. Understanding them helps investors assess risk and compare strategies effectively.
27,899 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Warren Buffett's successor, Greg Abel, is drawing new attention as recent 13F filings hint at a shift in Berkshire's ...
Micron looks cheaper than its earnings prospects suggest, but a closer look reveals cyclicality, demand swings, and r...
Oil’s surge fuels a wave of gains in key energy ETFs, led by XLE, OIH, and PBT, as supply, demand, and drilling budge...
As U.S. Treasury yields climb, the tax advantages of municipal bonds are under fresh scrutiny. High-income investors ...
Investors are eyeing a nuclear energy stock with outsized upside as regulatory momentum and a growing project pipelin...
Markets react to renewed chatter that spacex could soon file for a historic IPO, potentially reshaping space equities...
Applied Optoelectronics has rocketed higher in 2026, delivering a 439% year-to-date gain as hyperscale AI data center...
Microsoft stock has slipped in 2026, but a strong earnings report could ignite a rebound. This guide breaks down what...
A disciplined value-focused approach has outpaced the S&P 500 for almost five years, signaling a leadership shift as ...
Interpreting the bbcp 2026 earnings transcript reveals how BBCP is growing, where margins are headed, and what to exp...
Buffett’s retirement signals a new chapter for Berkshire Hathaway. Discover why move over, apple: berkshire could bec...